CERo Therapeutics
CERO
CERO was delisted on the 30th of October, 2025.
10 hedge funds and large institutions have $7.33M invested in CERo Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0.02% less ownership
Funds ownership: 0.03% → 0.01% (-0.02%)
17% less funds holding
Funds holding: 12 → 10 (-2)
31% less capital invested
Capital invested by funds: $10.6M → $7.33M (-$3.28M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$542K |
| 2 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$195K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$1.29M |
| 2 |
CS
Clear Street
New York
|
-$1.28M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$863K |
| 4 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
-$520K |
| 5 |
FIA
FNY Investment Advisers
New York
|
-$22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MC
1
Meteora Capital
Boca Raton,
Florida
| $1.84M | +$195K | +9 | +12% |
|
|
MTCM
2
Mint Tower Capital Management
Amsterdam,
Netherlands
| $1.53M | – | – | – |
|
|
YCM
3
Yakira Capital Management
Westport,
Connecticut
| $1.18M | – | – | – |
|
|
CS
4
Clear Street
New York
| $797K | -$1.28M | -59 | -61% |
|
|
SCM
5
Shaolin Capital Management
Miami,
Florida
| $543K | +$542K | +25 | New |
|
6
Walleye Capital
New York
| $521K | – | – | – |
|
|
WRBC
7
W.R. Berkley Corp
Greenwich,
Connecticut
| $513K | -$520K | -24 | -50% |
|
8
Walleye Trading
New York
| $293K | – | – | – |
|
9
Geode Capital Management
Boston,
Massachusetts
| $115K | – | – | – |
|
|
CF
10
Cantor Fitzgerald
New York
| $2 | – | – | – |
|
|
PAMP
11
Polar Asset Management Partners
Toronto,
Ontario, Canada
| – | -$1.29M | -60 | Closed |
|
|
AA
12
AQR Arbitrage
Greenwich,
Connecticut
| – | -$863K | -40 | Closed |
|
|
FIA
13
FNY Investment Advisers
New York
| – | -$22K | -1 | Closed |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| – | -$65 | – | – |
|
CERO Hedge Fund Activity: Q3 2023 in Review
10 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics (CERO) for Q3 2023, worth a combined $7.33M — down 31% from $10.6M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CERO and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $542K. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $1.29M sold.
- 10 institutional investors held CERo Therapeutics (CERO) as of Q3 2023, down from 12 in Q2 2023.
- Funds reported $7.33M of CERo Therapeutics stock for Q3 2023, down 31% quarter-over-quarter.
- 1 fund opened new CERo Therapeutics positions in Q3 2023 and 3 closed out, a net change of -2 holders.
- The largest CERo Therapeutics buyer in Q3 2023 was Shaolin Capital Management, an estimated $542K added.
- The largest CERo Therapeutics seller in Q3 2023 was Polar Asset Management Partners, an estimated $1.29M sold.
Based on aggregated 13F filings for Q3 2023.